(AMRN) Amarin - Performance 13.6% in 12m
AMRN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-80.71%
#135 in Peer-Group
Rel. Strength
57.43%
#3268 in Stock-Universe
Total Return 12m
13.58%
#56 in Peer-Group
Total Return 5y
-88.02%
#108 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 500 |
| High / Low | USD |
|---|---|
| 52 Week High | 16.81 USD |
| 52 Week Low | 8.00 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 95.43 |
| Buy/Sell Signal +-5 | 1.12 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AMRN (13.6%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: AMRN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AMRN
| Total Return (including Dividends) | AMRN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 41.24% | 3.36% | 5.25% |
| 3 Months | 107.77% | 15.73% | 24.13% |
| 12 Months | 13.58% | -7.02% | 14.15% |
| 5 Years | -88.02% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | AMRN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 86.4% | 4.4% | 81% |
| 3 Months | 95.4% | 78.8% | 96.9% |
| 12 Months | -38.5% | -85.8% | 44.9% |
| 5 Years | -95.6% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th95.00 | 36.66% | 34.20% |
| 3 Month | %th94.00 | 79.53% | 67.39% |
| 12 Month | %th72.50 | 22.16% | -0.50% |
| 5 Years | %th46.00 | -84.19% | -94.34% |
FAQs
Does Amarin (AMRN) outperform the market?
Yes,
over the last 12 months AMRN made 13.58%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months AMRN made 107.77%, while XBI made 15.73%.
Performance Comparison AMRN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AMRN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.8% | 36% | 53.6% | -1% |
| US NASDAQ 100 | QQQ | 5% | 35.9% | 52.9% | 1% |
| German DAX 40 | DAX | 6.9% | 42.7% | 41.4% | -15% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5% | 38% | 50.2% | -6% |
| Hongkong Hang Seng | HSI | 5.2% | 35.2% | 34.1% | -25% |
| India NIFTY 50 | INDA | 6.6% | 37.8% | 53.3% | 14% |
| Brasil Bovespa | EWZ | 2.3% | 32.4% | 28.5% | 4% |
AMRN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.2% | 35.3% | 49.5% | -11% |
| Consumer Discretionary | XLY | 5.3% | 38.1% | 61.2% | -4% |
| Consumer Staples | XLP | 4.5% | 40.6% | 51.9% | 5% |
| Energy | XLE | 4.5% | 34.2% | 57.7% | 14% |
| Financial | XLF | 4.1% | 36.2% | 48.7% | -16% |
| Health Care | XLV | 5.3% | 39.1% | 60.9% | 18% |
| Industrial | XLI | 4.7% | 37% | 45.7% | -11% |
| Materials | XLB | 2.5% | 37% | 49.1% | 8% |
| Real Estate | XLRE | 4.8% | 40.3% | 53.9% | 1% |
| Technology | XLK | 4% | 32.6% | 51.3% | 2% |
| Utilities | XLU | 5.9% | 39.5% | 50.4% | -9% |
| Aerospace & Defense | XAR | 6.9% | 34.2% | 35% | -36% |
| Biotech | XBI | 3.8% | 37.9% | 66.8% | 21% |
| Homebuilder | XHB | 2.3% | 34.2% | 60.8% | 8% |
| Retail | XRT | 2.3% | 36.3% | 57.9% | 2% |
AMRN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.9% | 32.8% | 62.0% | 21% |
| Natural Gas | UNG | 14.3% | 51.1% | 70.4% | 16% |
| Gold | GLD | 4.5% | 42.5% | 32.9% | -25% |
| Silver | SLV | 3.8% | 34.3% | 36.2% | -4% |
| Copper | CPER | 5.7% | 36.7% | 36.5% | 3% |
AMRN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6.6% | 40.2% | 57% | 16% |
| iShares High Yield Corp. Bond | HYG | 6% | 39.6% | 54.7% | 4% |